使Roflumilast:?

Gustavo Ferreira Alves1, Junior Garcia Oliveira2, Marcelo Almeida Nakashima2

  • 1Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Brazil; Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.

PubMed
概括

用罗夫米拉斯 (RFM) 抑制固-4 (PDE4) 抑制保护了败血症大鼠免受肝损伤和改善脏血流. 然而,RFM恶化了心血管功能障碍,并没有改善败血症的生存率.